Sozinibercept (Anti-VEGF-C/-D) Combined with Ranibizumab for Polypoidal Choroidal Vasculopathy: Phase IIb Predefined Subgroup Analysis

Purpose: The aim of this study was to assess the efficacy of sozinibercept, a novel “trap” inhibitor of VEGF-C and VEGF-D, when combined with ranibizumab for the treatment of polypoidal choroidal vasculopathy (PCV). Design: Prespecified subgroup analysis of a randomized, double-masked, sham-controll...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Chui Ming Gemmy Cheung, MD, FRCOphth, Timothy L. Jackson, PhD, FRCOphth, Charles C. Wykoff, MD, PhD, Arshad M. Khanani, MD, FASRS, Ian M. Leitch, PhD, Megan E. Baldwin, PhD, Jason Slakter, MD
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2025-07-01
Schriftenreihe:	Ophthalmology Science
Schlagworte:	Neovascular age-related macular degeneration Polypoidal choroidal vasculopathy Sozinibercept VEGF-C/-D
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2666914525000570
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!